Clinical Trial Update: Survival Prolongation by Rationale Innovative Genomics [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on survival outcomes for a regimen from Rationale Innovative Genomics in metastatic and stage IIIB non-small cell lung cancer; trial term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Worldwide Innovative Network Association | Conditions: Non-small Cell Lung Cancer Metastatic, Non-small Cell Lung Cancer Stage IIIB | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-12-18